Teva Pharmaceutical Industries | TEVA - Cash And Equivalent

Stock Price
9,270.00
Daily Change
71.00 0.77%
Monthly
-0.18%
Yearly
71.70%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $3.56B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 6.41B 5.93B Jun/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Guangzhou Baiy CNY 13.71B 1.88B Sep/2025
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Kalbe Farma IDR 4.05T 245.07B Sep/2025
Richter Gedeon HUF 135.63B 61.59B Dec/2024
Sh Fosun Pharma CNY 11.48B 1.48B Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025